vs
Concentra Group Holdings Parent, Inc.（CON）与伊萨（ESAB）财务数据对比。点击上方公司名可切换其他公司
伊萨的季度营收约是Concentra Group Holdings Parent, Inc.的1.3倍（$745.6M vs $569.6M），Concentra Group Holdings Parent, Inc.净利率更高（9.2% vs 6.6%，领先2.6%），Concentra Group Holdings Parent, Inc.同比增速更快（13.7% vs 9.9%）
Concentra是美国的职业医疗服务商，1979年成立于得克萨斯州阿马里洛，总部位于得克萨斯州艾迪生。业务覆盖美国47个州，运营627家职业医疗中心和410个雇主驻地现场诊所，美国每7起职业伤害案例中就有1起由该机构提供诊疗服务。
ESAB（全称Elektriska Svetsnings-Aktiebolaget）是一家美国与瑞典合资的跨国工业企业，主营焊接、切割设备及配套耗材的研发、生产与销售，为全球制造业、基建等多领域客户提供专业可靠的工业解决方案，在全球工业市场拥有较高知名度。
CON vs ESAB — 直观对比
营收规模更大
ESAB
是对方的1.3倍
$569.6M
营收增速更快
CON
高出3.8%
9.9%
净利率更高
CON
高出2.6%
6.6%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $569.6M | $745.6M |
| 净利润 | $52.3M | $49.2M |
| 毛利率 | — | 36.9% |
| 营业利润率 | 16.8% | 12.1% |
| 净利率 | 9.2% | 6.6% |
| 营收同比 | 13.7% | 9.9% |
| 净利润同比 | 28.7% | -29.3% |
| 每股收益（稀释后） | $0.39 | $0.78 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CONESAB
| Q1 26 | $569.6M | $745.6M | ||
| Q4 25 | $539.1M | $727.8M | ||
| Q3 25 | $572.8M | $715.6M | ||
| Q2 25 | $550.8M | $678.1M | ||
| Q1 25 | $500.8M | — | ||
| Q4 24 | — | $670.8M | ||
| Q3 24 | $489.6M | $673.3M | ||
| Q2 24 | $477.9M | $707.1M |
净利润CONESAB
| Q1 26 | $52.3M | $49.2M | ||
| Q4 25 | $34.7M | $54.8M | ||
| Q3 25 | $48.3M | $66.9M | ||
| Q2 25 | $44.6M | $67.4M | ||
| Q1 25 | $38.9M | — | ||
| Q4 24 | — | $53.7M | ||
| Q3 24 | $44.3M | $68.2M | ||
| Q2 24 | $51.7M | $82.9M |
毛利率CONESAB
| Q1 26 | — | 36.9% | ||
| Q4 25 | — | 37.0% | ||
| Q3 25 | — | 37.2% | ||
| Q2 25 | — | 37.6% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 38.5% | ||
| Q3 24 | — | 37.7% | ||
| Q2 24 | — | 38.2% |
营业利润率CONESAB
| Q1 26 | 16.8% | 12.1% | ||
| Q4 25 | 12.9% | 14.6% | ||
| Q3 25 | 16.5% | 15.2% | ||
| Q2 25 | 16.3% | 16.2% | ||
| Q1 25 | 16.0% | — | ||
| Q4 24 | — | 16.6% | ||
| Q3 24 | 17.6% | 15.7% | ||
| Q2 24 | 17.6% | 16.9% |
净利率CONESAB
| Q1 26 | 9.2% | 6.6% | ||
| Q4 25 | 6.4% | 7.5% | ||
| Q3 25 | 8.4% | 9.3% | ||
| Q2 25 | 8.1% | 9.9% | ||
| Q1 25 | 7.8% | — | ||
| Q4 24 | — | 8.0% | ||
| Q3 24 | 9.1% | 10.1% | ||
| Q2 24 | 10.8% | 11.7% |
每股收益（稀释后）CONESAB
| Q1 26 | $0.39 | $0.78 | ||
| Q4 25 | $0.27 | $0.90 | ||
| Q3 25 | $0.38 | $1.09 | ||
| Q2 25 | $0.35 | $1.10 | ||
| Q1 25 | $0.30 | — | ||
| Q4 24 | — | $0.87 | ||
| Q3 24 | $0.37 | $1.11 | ||
| Q2 24 | $0.50 | $1.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $1.0B |
| 总债务越低越好 | $1.6B | $2.0B |
| 股东权益账面价值 | $424.7M | $2.2B |
| 总资产 | $2.9B | $5.6B |
| 负债/权益比越低杠杆越低 | 3.68× | 0.91× |
8季度趋势，按日历期对齐
现金及短期投资CONESAB
| Q1 26 | — | $1.0B | ||
| Q4 25 | $79.9M | $218.2M | ||
| Q3 25 | $49.9M | $258.2M | ||
| Q2 25 | $73.9M | $291.3M | ||
| Q1 25 | $52.1M | — | ||
| Q4 24 | — | $249.4M | ||
| Q3 24 | $136.8M | $253.7M | ||
| Q2 24 | $50.7M | $228.5M |
总债务CONESAB
| Q1 26 | $1.6B | $2.0B | ||
| Q4 25 | $1.6B | $1.3B | ||
| Q3 25 | $1.6B | $1.1B | ||
| Q2 25 | $1.7B | $1.1B | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | $1.5B | $1.1B | ||
| Q2 24 | $3.0M | $1.1B |
股东权益CONESAB
| Q1 26 | $424.7M | $2.2B | ||
| Q4 25 | $393.3M | $2.1B | ||
| Q3 25 | $385.5M | $2.1B | ||
| Q2 25 | $342.6M | $1.9B | ||
| Q1 25 | $307.1M | — | ||
| Q4 24 | — | $1.8B | ||
| Q3 24 | $277.8M | $1.8B | ||
| Q2 24 | $1.2B | $1.7B |
总资产CONESAB
| Q1 26 | $2.9B | $5.6B | ||
| Q4 25 | $2.9B | $4.9B | ||
| Q3 25 | $2.8B | $4.4B | ||
| Q2 25 | $2.8B | $4.2B | ||
| Q1 25 | $2.7B | — | ||
| Q4 24 | — | $4.0B | ||
| Q3 24 | $2.5B | $4.1B | ||
| Q2 24 | $2.4B | $4.0B |
负债/权益比CONESAB
| Q1 26 | 3.68× | 0.91× | ||
| Q4 25 | 3.98× | 0.63× | ||
| Q3 25 | 4.15× | 0.51× | ||
| Q2 25 | 4.82× | 0.55× | ||
| Q1 25 | 5.27× | — | ||
| Q4 24 | — | 0.60× | ||
| Q3 24 | 5.30× | 0.59× | ||
| Q2 24 | 0.00× | 0.63× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.0M | $46.9M |
| 自由现金流经营现金流 - 资本支出 | $9.9M | — |
| 自由现金流率自由现金流/营收 | 1.7% | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 0.40× | 0.95× |
| 过去12个月自由现金流最近4个季度 | $211.0M | — |
8季度趋势，按日历期对齐
经营现金流CONESAB
| Q1 26 | $21.0M | $46.9M | ||
| Q4 25 | $118.7M | $81.5M | ||
| Q3 25 | $60.6M | $46.6M | ||
| Q2 25 | $88.4M | $35.4M | ||
| Q1 25 | $11.7M | — | ||
| Q4 24 | — | $126.9M | ||
| Q3 24 | $65.9M | $101.0M | ||
| Q2 24 | — | $83.0M |
自由现金流CONESAB
| Q1 26 | $9.9M | — | ||
| Q4 25 | $98.5M | $70.3M | ||
| Q3 25 | $39.4M | $37.4M | ||
| Q2 25 | $63.2M | $28.1M | ||
| Q1 25 | $-4.0M | — | ||
| Q4 24 | — | $102.2M | ||
| Q3 24 | $50.8M | $90.4M | ||
| Q2 24 | — | $74.0M |
自由现金流率CONESAB
| Q1 26 | 1.7% | — | ||
| Q4 25 | 18.3% | 9.7% | ||
| Q3 25 | 6.9% | 5.2% | ||
| Q2 25 | 11.5% | 4.1% | ||
| Q1 25 | -0.8% | — | ||
| Q4 24 | — | 15.2% | ||
| Q3 24 | 10.4% | 13.4% | ||
| Q2 24 | — | 10.5% |
资本支出强度CONESAB
| Q1 26 | — | — | ||
| Q4 25 | 3.7% | 1.5% | ||
| Q3 25 | 3.7% | 1.3% | ||
| Q2 25 | 4.6% | 1.1% | ||
| Q1 25 | 3.1% | — | ||
| Q4 24 | — | 3.7% | ||
| Q3 24 | 3.1% | 1.6% | ||
| Q2 24 | — | 1.3% |
现金转化率CONESAB
| Q1 26 | 0.40× | 0.95× | ||
| Q4 25 | 3.42× | 1.49× | ||
| Q3 25 | 1.26× | 0.70× | ||
| Q2 25 | 1.98× | 0.53× | ||
| Q1 25 | 0.30× | — | ||
| Q4 24 | — | 2.36× | ||
| Q3 24 | 1.49× | 1.48× | ||
| Q2 24 | — | 1.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CON
| Workers' compensation | $337.7M | 59% |
| Employer services | $172.4M | 30% |
| Onsite health clinics | $37.2M | 7% |
| Other | $14.5M | 3% |
| Consumer health | $7.8M | 1% |
ESAB
暂无分部数据
